IMA is world leader in the design and manufacture of automatic machines and complete lines for the processing and packaging of pharmaceutical products.
Continuous Manufacturing is one of the main drivers of innovation in the pharmaceutical production sector. CROMA, the new continuous tablet coating equipment, is IMA’s first step in this direction.
IMA Active is working on the continuous process by rethinking currently known technologies in order to bring new proposals for customers to the market as quickly as possible. When it comes to technologies for solid oral form production, IMA Active has chosen to start with the tablet coating process because it comes between two intrinsically continuous processes already managed by IMA machines: tablet pressing and packaging. CROMA, the new continuous tablet coating equipment, is sized to work downstream of a medium-speed tablet press.
IMA is committed to supporting the change towards Continuous Manufacturing. CROMA is the first step towards continuous production. IMA’s team is ready to welcome the demand for innovation coming from companies and stakeholders, working together to design the future of pharmaceutical manufacturing.
Company name: IMA S.p.A. - Active division
Website:www.ima.it
E-mail: mktg.soliddose@ima.it
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.